Anna Berand
Impact in
-
- Cancer Cells and Metastasis
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- Vascular Tumors and Angiosarcomas
Papers in
-
- Renal cell carcinoma treatment 4
- Prostate Cancer Treatment and Research 3
- Oncology 5
- Cutaneous Melanoma Detection and Management 4
- Cancer Immunotherapy and Biomarkers 1
- Vascular Tumors and Angiosarcomas 1
- Co-authors
- Albrecht Reichle (15 shared papers)Reinhard Andreesen (12 shared papers)THOMAS M. VOGT (5 shared papers)K. Bross (7 shared papers)Frauke Bataille (4 shared papers)Michael Landthaler (4 shared papers)Peter Johannes Wild (4 shared papers)Christian Matthias Hafner (1 shared paper)
- Journals
- Blood (2 papers)Cancer (2 papers)World Journal of Urology (1 paper)Medical Oncology (1 paper)PPAR Research (1 paper)
- Partner nations
- GermanySwitzerland
In The Last Decade
Anna Berand
14 papers receiving 382 citations
Peers
Comparison fields: 5 of 37
- Oncology 154
- Cancer Research 39
- Molecular Biology 170
- Pulmonary and Respiratory Medicine 69
- Modeling and Simulation 8
Countries citing papers authored by Anna Berand
This map shows the geographic impact of Anna Berand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Berand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Berand more than expected).
Fields of papers citing papers by Anna Berand
This network shows the impact of papers produced by Anna Berand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Berand. The network helps show where Anna Berand may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Berand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 126 | |
| 2 | 2004 | 88 | |
| 3 | 2007 | 47 | |
| 4 | 2009 | 43 | |
| 5 | 2011 | 27 | |
| 6 | C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation. | 2007 | 21 |
| 7 | 2010 | 13 | |
| 8 | 2010 | 12 | |
| 9 | 2006 | 8 | |
| 10 | 2005 | 2 | |
| 11 | 2010 | 2 | |
| 12 | 2010 | 2 | |
| 13 | 2010 | 2 | |
| 14 | 2007 | 1 | |
| 15 | 2010 | 0 |
About Anna Berand
Anna Berand is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pharmacology, Molecular Biology and Hematology, having authored 15 papers that have together received 394 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (4 papers), Renal cell carcinoma treatment (4 papers), Melanoma and MAPK Pathways (4 papers), Prostate Cancer Treatment and Research (3 papers), Inflammatory mediators and NSAID effects (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Vascular Tumors and Angiosarcomas (1 paper). The work is most often cited by research in Oncology (154 citations), Cancer Research (39 citations), Molecular Biology (170 citations), Pulmonary and Respiratory Medicine (69 citations) and Modeling and Simulation (8 citations). Anna Berand has collaborated with scholars based in Germany and Switzerland. Frequent co-authors include Albrecht Reichle, Reinhard Andreesen, THOMAS M. VOGT, K. Bross, Frauke Bataille, Michael Landthaler, Peter Johannes Wild, Christian Matthias Hafner, Karl‐Walter Jauch and Stefan W. Krause. Their work appears in journals such as Blood, Cancer, World Journal of Urology, Medical Oncology and PPAR Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.